Ultrastructural Changes Induced by Anabolic Steroids in Liver of Trained Rats

Total Page:16

File Type:pdf, Size:1020Kb

Ultrastructural Changes Induced by Anabolic Steroids in Liver of Trained Rats Histol Histopath (1993) 8: 449-455 Histology and Histopathology Ultrastructural changes induced by anabolic steroids in liver of trained rats R. Grageral, A. saborido2, F. ~olano~,L. ~irnenezl, E. ~uiiizland A. Megias2 'Department of Cell Biology, Faculty of Biology and 2Department of Biochemistry and Molecular Biology I, Faculty of Chemistry, Complutensis University, Madrid, Spain Summary. The effects of anabolic steroid treatment in have been shown in top-level and amateur athletes using association with endurance training on biochemical anabolic steroids (Wilson, 1988; Hickson et al., 1989; serum parameters and liver ultrastructure have been Lamb, 1989; Craham and Kennedy, 1990). In the case of investigated in male rats. Values of serum alanine oral anabolizing androgens, the presence of the 17a- aminotransferase, aspartate aminotransferase and alkyl group introduced to retard hepatic degradation, alkaline phosphatase were not significantly affected seems to be associated with hepatotoxic effects and, in by administration of high doses of fluoxymesterone fact, three cases of fatal liver tumours have been or methylandrostanolone. Electron microscopic reported in otherwise healthy athletes who had been examination of hepatic tissue from treated animals taking anabolic steroids for several years (Hickson et al., revealed ultrastructural alterations of hepatocytes. The 1989). Levels of enzymes and metabolites related to most prominent changes were swelling of mitochondria, hepatic function have been reported to be slightly which presented electron-lucent matrix and slightly elevated (Hakkinen and Alen, 1986; Lenders et al., defined cristae, and a marked increase in the number 1988) or not substantially modified (Alen, 1985; Ballarin of lysosomes. These changes were evident in both et al., 1986; Thompson et al., 1989) in the serum of sedentary and trained treated rats, indicating that liver athletes using different anabolic steroids. However, the cell damage is produced by anabolic-androgenic steroids possibility of liver lesions not being detected by despite the simultaneous realization of physlcal exercise. conventional liver function tests exists. The alterations observed were not detected by means of It is well-known that androgens modulate several conventional biochemical liver tests. hepatic functions such as metabolism of lipoproteins, steroids, drugs, ... (Rahwan, 1988). Likewise, Key words: Fluoxymesterone, Methylandrostanolone, morphometric analysis of rat liver after castration shows Hepatotoxic effects, Serum enzymes, Exercise training a significant reduction in the number of hepatocytes (Tanganelli et al., 1988). The anabolic-androgenic steroids, although exhibiting some of the characteristics Introduction and actions of the endogenous androgens, could be regarded in the high doses taken by athletes as a Anabolic-androgenic steroids, a group of synthetic xenobiotic load for the liver, probably related to compounds structurally related to testosterone, are used functional and structural alterations of this organ. On the in medical practice in status of muscle wasting or other hand, exercise is known to influence a large debilitation, to stimulate erythropoiesis in some anaemia number of physiological factors (haemodynamics, blood and in the treatment of hypogonadal status (Rahwan, pH, body temperature, etc.) which may affect the 1988). They are also taken in high doses by athletes who pharmacokinetics of numerous drugs. Thus, the wish to improve physical performance (Wilson, 1988; concurrence of training and anabolic steroid ingestion Lamb, 1989). Although adverse effects have been could be expected to modify the potential hepatotoxicity reported in patients treated with these compounds (Ishak of these compounds. Nevertheless, to date information and Zimmerman, 1987; S0e et al., 1992), knowledge about the effects of anabolic-androgenic steroid about the side effects of suprapharmacological doses of treatment and simultaneous exercise training on liver anabolic steroids in athletes is limited. Reduced levels of structure is scarce. Pathological changes indicative of serum high density lipoproteins and testicular atrophy cholestasis have been observed in the liver of motor- active mice (Mus wagneri rotans) after 4 weeks of Offprint requests to: Dra. Alicia Megias, Department of Biochemistry, methandrostenolone treatment (Stang-Voss and Appell, Faculty of Chemistry, Complutensis University, 28040 Madrid, Spain 1981), but the relevance of this model with respect to the Steroids and liver of trained rats physical training of athletes is questionable. blood was collected by cardiac puncture. Serum was The purpose of the present work was to study the obtained by centrifugation at 3000g for 15 min, effects of a prolonged treatment with high doses of oral aliquoted and stored at -40 "C for enzyme assays. anabolizing androgens, in association with endurance Aspartate aminotransferase (AST), alanine amino- training, on rat liver ultrastructure and levels of serum transferase (ALT) and alkaline phosphatase (ALP) were parameters related to hepatic function. The results show analyzed by using commercial kits from Bohringer that anabolic-androgenic steroids induce ultrastructural (Bohringer Biochemica GmbH, Mannheim, Germany). changes in liver cells although hepatic function Total and direct bilirubin were determined in fresh serum indicators in serum are not modified. Exercise training aliquots by a calorimetric procedure (Arnes, Miles does not prevent the morphological alterations observed. Italiana S.p.A., Milano, Italy). Materials and methods Electron microscopy Anabolic-androgenic steroids For electron microscopy, livers of the animals from the different groups were perfused with 2.5% Fluoxymesterone (1 113, 1713-dihydroxy-9a-fluoro- glutaraldehyde in Millonig's buffer, pH 7.3, and quickly 17a-methyl-4-androsten-3-one) and methyl- removed. Small tissue specimens were post-fixed in androstanolone (1713-hydroxy- l7a-methyl-5a- buffered 2% osmium tetroxide, dehydrated in a graded androstan-3-one) were obtained from Sigma Chemical series of acetone and embedded in Araldite. Ultrathin CO (St. Louis, MO. USA). sections were cut by a diamond knife with a Reichert UM-2 ultra-microtome and stained with uranyl acetate Training programme and anabolic-androgenic steroid and lead citrate. Observations were carried out on a treatment Philips EM-201 electron microscope. Male Wistar rats (initial body weight 115 + 5 g) were Statistical analysis obtained from Charles River (Barcelona, Spain). Animals had free access to laboratory chow and tap In these experiments, values of serum parameters water. They were maintained on a 12: 12 h light-dark were analyzed using two-way analysis of variance cycle and housed in an animal room where temperature (ANOVA: factor l= exercise training; factor 2 = steroid (22-24 "C) and humidity (65-75%) were controlled. treatment). If an overall significant F value was Thirty-six rats were randomly divided into sedentary obtained, a Scheffk post hoc analysis was performed. A and exercise training groups. The animals of the trained level of p < 0.05 was selected to indicate statistical group were exercised by running on a motor-driven significance. treadmill 5 dayslweek for 12 weeks. During the first 4 weeks, the speed and duration of the daily exercise Results sessions were progressively increased until the rats were capable of running continuously for 45 min at 25 mlmin. The training programme used in these experiments At the beginning of the fifth training week, when induced a significant decrease in the body weight of the maximal exercise intensity was reached, each group was exercised animals when compared to the sedentary arbitrarily subdivided into three groups: control; controls (Table 1). On the other hand, body weight of the fluoxymesterone-treated; and methylandrostanolone- rats was not affected by anabolic steroid treatment, as treated. The animals selected for anabolic-androgenic shown in Table 1. This fact suggests that abnormal steroid treatment received by gastric intubation 2 mg retention of fluids was not produced as a consequence of steroidkg body weight, as a homogeneous suspension in the anabolizing androgen administration. 1 ml of water, 5 days per week for 8 weeks. The high The determination of metabolites and enzyme level of anabolizing androgens was chosen in an attempt activities in the serum can be of great value for the to simulate the massive doses of anabolic-androgenic detection of toxic effects on the liver. In this respect, steroids reported to be used in athletics (Wilson, 1988). mean values of serum bilirubin as well as transaminases An additional group of six sedentary rats received 5 mg and alkaline phosphatase activities remained within fluoxymesterone/kg body weight for 8 weeks, following normal range in all the groups studied (Table 1). These the same protocol described above. results suggest that neither exercise training nor the administration of anabolic-androgenic steroids induced Serum analyses modifications in the liver function, being consistent with those obtained with power athletes who self- After completion of the 12-week exercise administered very high doses of testosterone and programme, rats were not exercised for 36-44 h and anabolic steroids (Alen, 1985; Ballarin et al., 1986; received the last dose 14-18 h before they were Thompson et al., 1989). sacrificed (between 8:00 and 12:OO a.m.). Animals were The principal features of the hepatic cells in trained
Recommended publications
  • Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
    Journal of Clinical Medicine Review Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals Carlotta Cocchetti 1, Jiska Ristori 1, Alessia Romani 1, Mario Maggi 2 and Alessandra Daphne Fisher 1,* 1 Andrology, Women’s Endocrinology and Gender Incongruence Unit, Florence University Hospital, 50139 Florence, Italy; [email protected] (C.C); jiska.ristori@unifi.it (J.R.); [email protected] (A.R.) 2 Department of Experimental, Clinical and Biomedical Sciences, Careggi University Hospital, 50139 Florence, Italy; [email protected]fi.it * Correspondence: fi[email protected] Received: 16 April 2020; Accepted: 18 May 2020; Published: 26 May 2020 Abstract: Introduction: To date no standardized hormonal treatment protocols for non-binary transgender individuals have been described in the literature and there is a lack of data regarding their efficacy and safety. Objectives: To suggest possible treatment strategies for non-binary transgender individuals with non-standardized requests and to emphasize the importance of a personalized clinical approach. Methods: A narrative review of pertinent literature on gender-affirming hormonal treatment in transgender persons was performed using PubMed. Results: New hormonal treatment regimens outside those reported in current guidelines should be considered for non-binary transgender individuals, in order to improve psychological well-being and quality of life. In the present review we suggested the use of hormonal and non-hormonal compounds, which—based on their mechanism of action—could be used in these cases depending on clients’ requests. Conclusion: Requests for an individualized hormonal treatment in non-binary transgender individuals represent a future challenge for professionals managing transgender health care. For each case, clinicians should balance the benefits and risks of a personalized non-standardized treatment, actively involving the person in decisions regarding hormonal treatment.
    [Show full text]
  • Part I Biopharmaceuticals
    1 Part I Biopharmaceuticals Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 3 1 Analogs and Antagonists of Male Sex Hormones Robert W. Brueggemeier The Ohio State University, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Columbus, Ohio 43210, USA 1Introduction6 2 Historical 6 3 Endogenous Male Sex Hormones 7 3.1 Occurrence and Physiological Roles 7 3.2 Biosynthesis 8 3.3 Absorption and Distribution 12 3.4 Metabolism 13 3.4.1 Reductive Metabolism 14 3.4.2 Oxidative Metabolism 17 3.5 Mechanism of Action 19 4 Synthetic Androgens 24 4.1 Current Drugs on the Market 24 4.2 Therapeutic Uses and Bioassays 25 4.3 Structure–Activity Relationships for Steroidal Androgens 26 4.3.1 Early Modifications 26 4.3.2 Methylated Derivatives 26 4.3.3 Ester Derivatives 27 4.3.4 Halo Derivatives 27 4.3.5 Other Androgen Derivatives 28 4.3.6 Summary of Structure–Activity Relationships of Steroidal Androgens 28 4.4 Nonsteroidal Androgens, Selective Androgen Receptor Modulators (SARMs) 30 4.5 Absorption, Distribution, and Metabolism 31 4.6 Toxicities 32 Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 4 Analogs and Antagonists of Male Sex Hormones 5 Anabolic Agents 32 5.1 Current Drugs on the Market 32 5.2 Therapeutic Uses and Bioassays
    [Show full text]
  • Anabolic Steroids
    epartment .D of .S Ju U s t ic U.S. Department of Justice e . n o Drug Enforcement Administration i t a r t is Office of Diversion Control D in Laws and penalties for anabolic r m ug d E t A steroid abuse (cont’d) nforcemen an individual’s first drug offense. The maximum www.dea.gov penalty for trafficking is five years in prison and a For more information: fine of $250,000 if this is the individual’s first felony drug offense. If this is the second felony drug offense, the maximum period of imprisonment and Please contact your nearest the maximum fine both double. The period of DEA office imprisonment and the amount of fine are enhanced Or if the offense involves the distribution of an anabolic Visit one of our Internet Websites: steroid and a masking agent or if the distribution is to an athlete. In addition, enhanced penalties exist www.DEAdiversion.usdoj.gov for any athletic coach who uses his/her position to Or influence an athlete to use an anabolic steroid. While www.dea.gov the above listed penalties are for federal offenses, individual states have also implemented fines and penalties for illegal use of anabolic steroids. The International Olympic Committee (IOC), National Collegiate Athletic Association (NCAA), and many professional sports leagues (e.g. Major League Baseball, National Basketball Association, National Football League , and National Hockey League) have banned the use of steroids by athletes, both because of their potential dangerous side effects and they give the user an unfair advantage.
    [Show full text]
  • Adverse Effects of Anabolic-Androgenic Steroids: a Literature Review
    healthcare Review Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review Giuseppe Davide Albano 1,†, Francesco Amico 1,†, Giuseppe Cocimano 1, Aldo Liberto 1, Francesca Maglietta 2, Massimiliano Esposito 1, Giuseppe Li Rosi 3, Nunzio Di Nunno 4, Monica Salerno 1,‡ and Angelo Montana 1,*,‡ 1 Legal Medicine, Department of Medical, Surgical and Advanced Technologies, “G.F. Ingrassia”, University of Catania, 95123 Catania, Italy; [email protected] (G.D.A.); [email protected] (F.A.); [email protected] (G.C.); [email protected] (A.L.); [email protected] (M.E.); [email protected] (M.S.) 2 Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy; [email protected] 3 Department of Law, Criminology, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy; [email protected] 4 Department of History, Society and Studies on Humanity, University of Salento, 73100 Lecce, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-095-3782153 † These authors contributed equally to this work. ‡ These authors share last authorship. Abstract: Anabolic-androgenic steroids (AASs) are a large group of molecules including endoge- nously produced androgens, such as testosterone, as well as synthetically manufactured derivatives. AAS use is widespread due to their ability to improve muscle growth for aesthetic purposes and athletes’ performance, minimizing androgenic effects. AAS use is very popular and 1–3% of US inhabitants have been estimated to be AAS users. However, AASs have side effects, involving all organs, tissues and body functions, especially long-term toxicity involving the cardiovascular system Citation: Albano, G.D.; Amico, F.; and the reproductive system, thereby, their abuse is considered a public health issue.
    [Show full text]
  • 36148 Federal Register / Vol
    36148 Federal Register / Vol. 85, No. 115 / Monday, June 15, 2020 / Rules and Regulations Sundstrand) model 54H60 propellers with a collection of information subject to the Administration (NARA). For information on blade having a serial number (S/N) below requirements of the Paperwork Reduction the availability of this material at NARA, S/N 813320. Act unless that collection of information email: [email protected], or go to: displays a currently valid OMB Control https://www.archives.gov/federal-register/cfr/ (d) Subject Number. The OMB Control Number for this ibr-locations.html. Joint Aircraft System Component (JASC) information collection is 2120–0056. Public Issued on June 3, 2020. Code 6111, Propeller Blade Section. reporting for this collection of information is estimated to be approximately 1 hour per Lance T. Gant, (e) Unsafe Condition response, including the time for reviewing Director, Compliance & Airworthiness This AD was prompted by the separation instructions, searching existing data sources, Division, Aircraft Certification Service. of a propeller blade that resulted in the loss gathering and maintaining the data needed, [FR Doc. 2020–12821 Filed 6–12–20; 8:45 am] of an airplane and 17 fatalities. The FAA is completing and reviewing the collection of BILLING CODE 4910–13–P issuing this AD to detect cracking in the information. All responses to this collection propeller blade taper bore. The unsafe of information are mandatory. Send condition, if not addressed, could result in comments regarding this burden estimate or failure of the propeller blade, blade any other aspect of this collection of DEPARTMENT OF JUSTICE separation, and loss of the airplane.
    [Show full text]
  • The Combined Cardiac Effect of the Anabolic Steroid, Nandrolone And
    ù1. v -¿. rlc) 77.- *n*hi.rnool oowol,ù*o ffi"/fu -lo *rn*(o fii'o fio¿o¿¿, /v&"ùún lonno **al cooaiæe';¿vfl"- oã. Benjamin D. Phillis, B.Sc. (Hons) Phatmacology Depattment of Clinical & Experimental Pharmacology Ftome Rd. , Medical School Noth Adelaide Univetsity ADEIAIDE SA 5OOO û.)r.'-*hr/7enveltîù Foremost, I would like to thank my two supervisors for the direction that they have given this ptojecr. To Rod, for his unfailing troubleshooting abiJity and to Jenny fot her advice and ability to add scientific rigour' Many thanks to Michael Adams for his technical assistance and especially fot performing the surgery for the ischaemia-reperfusion projects and for his willingness to work late nights and public holidays. Lastly I would like to thank my v¡ife for her extreme patience during the tumult of the last 5 years. Her love, suppoït, patience and undetstanding have been invaluable in this endeavout. Beniamin D. Phillis Octobet,2005 ADE,I-AIDE ii T*(¿t of Ao,t",tù DECI.ARATION I ACKNOWLEDGEMENTS il TABLE OF CONTENTS UI ABBREVIATIONS x ABSTRACT )ilr CÉIAPTER t-l Inttoduction 1-1 1.1 Background 1,-1, 1.2What ate anabolic stetoids? 7-1 1,3 General pharmacology of Anabolic steroids t-2 '1,-2 1.3.1 Genomic effects of anabolic steroids 1.3.2 Non-genomic effects of anabolic steroids 1-3 1.4 Clinical use of AS 1.-4 1.5 Patterns of AS abuse 1.-4 1.5.1 Steroid abuse by athletes 1.-+ 1.5.2 Stetoid abuse by sedentary teenagers r-6 1.5.3 Prevalence of abuse 1-6 1.5.4 Abuse ptevalence in Australia 1.-9 1.6 Cardiotoxicity of anabolic steroids r-9 1.6.1 Reduced cotonary flow 1.-1.1, 1,.6.2 Dtect myocatdial eff ects 1-1 5 1.6.3 Hypertension 1-21 1.7 Difficulties associated with anabolic steroid research 1.-24 1-25 1.8 The polydrug abuse Phenomenon 1.9 The pharmacology of cocaine 1-26 1.10 Pteparations 1-28 1-29 1.11 Metabolism lll 1-30 1.
    [Show full text]
  • Hepatotoxic and Cardiotoxic Effects of Testosterone Enanthate Abuse on Adult Male Albino Rats
    Al-Azhar Med. J.( Medicine). Vol. 50(2), April, 2021, 1335 - 1348 DOI: 10.12816/amj.2021.158480 https://amj.journals.ekb.eg/article_158480.html HEPATOTOXIC AND CARDIOTOXIC EFFECTS OF TESTOSTERONE ENANTHATE ABUSE ON ADULT MALE ALBINO RATS By Mohamed Abd El-Aziz El-Gendy, Fouad Helmy El-Dabbah, Ashraf Ibrahim Hassan and Naser Abd El-Naby Awad* Departments of Forensic Medicine & Clinical Toxicology and Pathology*, Al-Azhar Faculty of Medicine, Egypt E-mail: [email protected] ABSTRACT Background: Anabolic androgenic steroids (AASs) represent a group of synthetic derivatives of testosterone created to maximize anabolic effects and minimize the androgenic ones. Athletes use anabolic androgenic steroids (AAS) to enhance performance regardless of the health risk they may impact in some persons. Objective: To study the histopathological and biochemical changes that could occur on liver and cardiac muscle after administration of doping dose (supraphysiological dose) of testosterone enanthate (one of AAS). Materials and Methods: One hundred (100) male albino rats were included in the present study and divided into six groups. Group (1a); negative control group, Group (1b) positive control group treated with therapeutic dose of testosterone Enanthate (10 mg /Kg body weight intramuscular / I.M weekly for 12 weeks), group (2) was treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M for 4 weeks), group (3) was treated with treated with doping dose of testosterone enanthate (60 mg /Kg body weight / I.M weekly for 8 weeks), group (4) treated with doping dose of testosterone enanthate (60 mg /Kg body weight / I.M weekly for 12 weeks), group (5a) treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M/ weekly for 12 weeks followed by 2 weeks of treatment discontinuation) , group (5b) treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M weekly for 12 weeks followed by 4 weeks of treatment discontinuation).
    [Show full text]
  • Designer Steroids“ Nor- Bolethone, Desoxymethyltestosterone and Tetrahydrogestrinone: Endocrine Pharmacological Characteristics and Side Effects in Regard to Doping
    The so-called „designer steroids“ Nor- bolethone, Desoxymethyltestosterone and Tetrahydrogestrinone: Endocrine pharmacological characteristics and side effects in regard to doping. Tsuyuki Nishino, Thorsten Schulz, Renate Oberhoffer, R. Klaus Müller, Horst, Michna† Abstract The anabolic androgenic steroids belong to the list of prohibited substances given by the WADA´s List Committee. In fact, not all the biological and toxicological risks especially when administered for doping purposes are unknown. Thus, we completely characterized the substances Norbolethone, Desoxymethyltestosterone (DMT) or Tetrahydrogestrinone (THG) concerning their endocrine and pharmacological properties. Besides conceiving chemical possibilities to access the modified steroids, we character- ized their hormonal potential using modified industrial methods like Hershberger and Clauberg assays. The synthesis of Norbolethone starts with Norgestrel and its nickel-catalyzed hydrogena- tion resulting in Norbolethone. Norbolethone caused a lot of bleeding disorders and many andro- genizing side effects. DMT is an anabolic steroid, which was synthesized and patented in 1961. The synthesis of DMT starts with epiandrosterone, a natural reduction product of testosterone that is excreted in urine. DMT is a potent anabolic compound and therefore it should be considered as a toxic drug. No (anti-)gestagenic, (anti-)estrogenic or (anti-)glucocorticoid potency could be detected. The synthesis of THG starts with gestrinone and its nickel-catalyzed hydrogenation resulting in THG. By modifying the 17α-position, THG becomes orally active. THG is a very strong anabolic agent with an increased risk of liver damage and the incidence of general side effects usually caused by steroids. THG, like other anabolic steroids, exerts androgenic and pro- gestational effects in the standard assays to predict activity in humans.
    [Show full text]
  • Anabolic Steroids Anabolic Steroids
    Anabolic Steroids in Medicine Doctors never prescribe anabolic steroids for building muscle in young, healthy people. (Try push-ups instead!) But doctors sometimes prescribe anabolic The Brain’s Response to steroids to treat some types of anemia or disorders in men that prevent the normal production of testosterone. Anabolic Steroids You may have heard that doctors Hi, my name’s Sara Bellum. Welcome to my magazine series sometimes prescribe steroids to exploring the brain’s response to drugs. In this issue, we’ll investigate reduce swelling. This is true, but the fascinating facts about anabolic steroids. these aren’t anabolic steroids. They’re corticosteroids. Anabolic steroids are artificial versions of a Since corticosteroids don’t build hormone that’s in all of us—testosterone. muscles the way that anabolic (That’s right, testosterone is in girls as well steroids do, people don’t abuse as guys.) Testosterone not only brings them. out male sexual traits, it also causes muscles to grow. Some people take anabolic steroid pills or injections to try to build muscle faster. (“Anabolic” means STEROIDS growing or building.) 1) Anabolic steroids can affect the hypothalamus. 2) Anabolic steroids strengthen the immune But these steroids also have True system. other effects. They can cause or 3) Anabolic steroids can cause males’ breasts to changes in the brain and grow and females’ breasts to shrink. body that increase risks for False True. 3) False, 2) True, 1) illness, and they may also affect moods. The Search Continues There’s still a whole lot that scientists don’t Until then, join me—Sara Bellum—in know about the effects of anabolic steroids the other magazines in my series, as we on the brain.
    [Show full text]
  • Effect of Nandrolone Decanoate (Anabolic
    b Meta olis g m & ru D T o f x o i Journal of Drug Metabolism and l c a o n l o Mwaheb et al., J Drug Metab Toxicol 2017, 8:1 r g u y o J Toxicology DOI: 10.4172/2157-7609.1000224 ISSN: 2157-7609 Research Article Open Access Effect of Nandrolone Decanoate (Anabolic Steroid) on the Liver and Kidney of Male Albino Rats and the Role of Antioxidant (Antox-Silymarin) as Adjuvant Therapy Amal RS Mohammed1, Ghada M Al-Galad1, Amro A Abd-Elgayd1, Marwa A Mwaheb1* and Hala M Elhanbuli2 Department of Forensic Medicine and Clinical Toxicology, Fayoum University, Egypt 2Department of Pathology, Fayoum University, Egypt *Corresponding author: Marwa A Mwaheb, Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Fayoum University, Egypt, Tel: 0201006267354; E-mail: [email protected] Received date: January 3, 2017; Accepted date: January 25, 2017; Published date: February 1, 2017 Copyright: © 2017 Mwaheb MA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background and objective: The present study is determining the effect of Nandrolone Decanoate (ND) administration on the liver and kidney of white male albino rats. In addition, study the possible protective effect of administration of Antox and Silymarin on ND. Methods: The sample consisted of 110 male albino rats that divided into eleven groups treated by Nandrolone Decanoate at a dose of 7.93 mg/kg and 11.9 mg/kg then treated by Silymarin or Antox or both for 8 weeks.
    [Show full text]
  • Androgens and Anabolic Steroids Prior Authorization with Quantity Limit Through Preferred
    Androgens and Anabolic Steroids Prior Authorization with Quantity Limit Through Preferred Topical Androgen Criteria Program Summary This prior authorization program will apply only to the Oral and Topical Androgens and Anabolic Steroids. Quantity limits only apply to the topical androgen agents. OBJECTIVE The intent of the Androgens and Anabolic Steroids Prior Authorization (PA) program is to appropriately select patients for therapy according to product labeling and/or clinical guidelines and/or clinical studies and according to dosing recommended in product labeling. The PA criteria will approve these products for the FDA approved indications and off label use that is medically necessary for certain indications (AIDS/HIV-associated wasting syndrome, Turner Syndrome). In addition, the program will encourage use of the preferred topical androgen products prior to a nonpreferred topical androgen product. Use of a nonpreferred topical androgen product will be evaluated if the prescriber indicates a history of a trial of or documented intolerance, FDA labeled contraindication, or hypersensitivity to a preferred topical androgen product. Additionally, stand-alone topical products will not require the use of preferred topical products, nor be a requirement prior to use of nonpreferred topical products. The program will approve only one of these products at a time. The program will approve topical and injectable androgens for doses within the FDA labeled dosage range. Determination of quantity limits takes into account the packaging of the
    [Show full text]
  • Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects
    Touro Scholar Faculty Publications & Research of the TUC College of Pharmacy College of Pharmacy 2018 Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects Youwei Bi Paul J. Perry Touro University California, [email protected] Michael Ellerby Touro University California, [email protected] Daryl J. Murry Follow this and additional works at: https://touroscholar.touro.edu/tuccop_pubs Part of the Hormones, Hormone Substitutes, and Hormone Antagonists Commons Recommended Citation Bi, Y., Perry, P. J., Ellerby, M., & Murry, D. J. (2018). Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects. CPT: Pharmacometrics & Systems Pharmacology, 7 (4), 259-268. https://doi.org/10.1002/psp4.12287 Citation: CPT Pharmacometrics Syst. Pharmacol. (2018) 7, 259–268; doi:10.1002/psp4.12287 VC 2018 ASCPT All rights reserved ORIGINAL ARTICLE Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects Youwei Bi1, Paul J. Perry1,2, Michael Ellerby2 and Daryl J. Murry3* A randomized, double-blind clinical trial was conducted to investigate long-term abuse effects of testosterone cypionate (TC). Thirty-one healthy men were randomized into a dose group of 100, 250, or 500 mg/wk and received 14 weekly injections of TC. A pharmacokinetic/pharmacodynamic (PK/PD) model was developed to characterize testosterone concentrations and link exposure to change in luteinizing hormone and spermatogenesis following long-term TC administration. A linear one- compartment model best described the concentration-time profile of total testosterone. The population mean estimates for testosterone were 2.6 kL/day for clearance and 14.4 kL for volume of distribution.
    [Show full text]